Alkermes
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.About ALKS
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL.
ALKS Key Statistics
Stock Snapshot
The current Alkermes(ALKS) stock price is $29.52, with a market capitalization of 4.87B. The stock trades at a price-to-earnings (P/E) ratio of 14.50.
On 2025-12-05, Alkermes(ALKS) stock traded between a low of $28.97 and a high of $29.59. Shares are currently priced at $29.52, which is +1.9% above the low and -0.2% below the high.
The Alkermes(ALKS)'s current trading volume is 1.81M, compared to an average daily volume of 1.74M.
In the last year, Alkermes(ALKS) shares hit a 52-week high of $36.45 and a 52-week low of $25.17.
In the last year, Alkermes(ALKS) shares hit a 52-week high of $36.45 and a 52-week low of $25.17.
ALKS News
In the third quarter of 2025, Alkermes reported earnings from continuing operations of US$0.49 per share, surpassing expectations as its proprietary products po...
Alkermes (ALKS) gained attention after its third quarter earnings surpassed consensus expectations. Sales growth from Vivitrol, Aristada, and Lybalvi contribute...